D002318DisordersC1457021890.379883Cardiovascular DiseasesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonSANKARNAVANEETHANSANKAR NAVANEETHAN10348NAVANEETHAN, SANKARProfessor74Professor6Adjunct ProfessorCHARLESHENNEKENSCHARLES HENNEKENS12088HENNEKENS, CHARLESAdjunct Professor36.54490.000883076570research area of0.9981040.00929841691subject area forDepartment of MedicineDepartment of Family and Community MedicineFamily & Community MedicineMedicine-Athero & LipoproteinsMedicine-NephrologyBaylor College of MedicineCHRISTIEBALLANTYNECHRISTIE BALLANTYNE29.70978600000000-95.399866000000002252BALLANTYNE, CHRISTIEProfessorSALIMVIRANISALIM VIRANI29.70978600000000-95.399866000000003676VIRANI, SALIMAdjunct ProfessorVIJAYNAMBIVIJAY NAMBI29.70978600000000-95.39986600000000609NAMBI, VIJAYProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Adjunct ProfessorAdjunct Professortrue1ProfessorProfessor37556371Ramirez Bustamante CE, Agarwal N, Cox AR, Hartig SM, Lake JE, Balasubramanyam AEndocrine reviewsAdipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV. Endocr Rev. 2024 Mar 04; 45(2):190-209.Endocr Rev2024-03-04T00:00:002024Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV.38207208Short NJ, Jabbour E, Jain N, Senapati J, Nasr L, Haddad FG, Li Z, Hsiao YC, Yang JJ, Pemmaraju N, Ohanian M, Wierda WG, Montalban-Bravo G, Borthakur G, Han L, Xiao L, Huang X, Abramova R, Zhao M, Garris R, Konopleva M, Ravandi F, Kantarjian HBlood advancesA phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood Adv. 2024 Feb 27; 8(4):909-915.Blood Adv2024-02-27T00:00:002024A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.38294787Zhang Y, Dron JS, Bellows BK, Khera AV, Liu J, Balte PP, Oelsner EC, Amr SS, Lebo MS, Nagy A, Peloso GM, Natarajan P, Rotter JI, Willer C, Boerwinkle E, Ballantyne CM, Lutsey PL, Fornage M, Lloyd-Jones DM, Hou L, Psaty BM, Bis JC, Floyd JS, Vasan RS, Heard-Costa NL, Carson AP, Hall ME, Rich SS, Guo X, Kazi DS, de Ferranti SD, Moran AEJAMA cardiologyFamilial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol. JAMA Cardiol. 2024 Mar 01; 9(3):263-271.JAMA Cardiol2024-03-01T00:00:002024Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.38437690Koutroumpakis E, Deswal AAnnals of internal medicineIn adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med. 2024 Mar; 177(3):JC31.Ann Intern Med2024-03-05T00:00:002024In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo.true1Adjunct ProfessorAdjunct Professor38497469Smith C, Berry JD, Scherzer R, de Lemos JA, Nambi V, Ballantyne CM, Kravitz RL, Killeen AA, Ix JH, Shlipak MG, Ascher SBJournal of the American Heart AssociationIntensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT. J Am Heart Assoc. 2024 Mar 19; 13(6):e032493.J Am Heart Assoc2024-03-18T00:00:002024Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT.